Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy

Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy

286547

Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy

Pipeline Therapeutics announced that it has raised $80 million in investor financing to develop neuroregenerative therapies for neurological disorders, including those like multiple sclerosis (MS) that are marked by the loss of myelin. The money will support the research and development of several candidate therapies, with three aimed at promoting and restoring neuronal health. “We are proud to have this significant support for our mission of developing first- and best-in-class neuroregenerative product candidates for unserved and underserved…

You must be logged in to read/download the full post.